GAL and ovarian cancer: OTX008 is a phenyl-based molecule that binds the CRD of Gal-1 and has been shown to inhibit tumor cell survival and angiogenesis in ovarian cancer cell lines and synergizes with chemo- and immunotherapies in vitro [168,169].